Entasis Therapeutics

+$0.07 (+3.70%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ETTX and other stocks, options, and ETFs commission-free!

About ETTX

Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections.

CEO
Manoussos Perros
Employees
47
Headquarters
Waltham, Massachusetts
Founded
2015

ETTX Key Statistics

Market Cap
71.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
661.84K
High Today
$1.97
Low Today
$1.87
Open Price
$1.90
Volume
292.14K
52 Week High
$4.25
52 Week Low
$1.58

ETTX Earnings

-$1.15
-$0.77
-$0.38
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.36 per share
Actual
-$0.29 per share

You May Also Like

FIIIW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure